Official Title
COVID-19 and Pregnancy Outcomes: a Portuguese Collaboration Study
Brief Summary

This is a multicenter prospective study that aims to investigate the clinical impact ofSARS-CoV-2 infection in pregnant women, pregnancy outcomes and perinatal transmission.

Detailed Description

This is a cohort study of pregnant women confirmed positive for SARS-CoV-2 infection.
Data will be collected in Portuguese maternities that agreed to collaborate in this
study.

Pregnant women are tested during hospital admission by using nasopharyngeal/oral swabs
for SARS-CoV-2 RT PCR as part of a universal testing policy. Maternal demographic data
(age, comorbidities, parity, smoking habits), COVID-19 related data (symptoms, diagnostic
tests, therapy used and ICU admission), gestational age at SARS-CoV-2 confirmed
infection, pregnancy outcomes (gestational complications, gestational age at birth, mode
of delivery) and neonatal outcome (birthweight and Apgar score, RT PCR neonate results)
and breastfeeding strategies will be evaluated.

Unknown status
Coronavirus Infection
Pregnancy Complications
Vertical Transmission of Infectious Disease
Breastfeeding
Neonatal Infection

Diagnostic Test: RT PCR SARS-CoV-2

Positive SARS-CoV-2 RT PCR in nasopharyngeal/oral swab tests or presence of IgM in blood
samples
Other Name: SARS-COV-2 Serologic test

Eligibility Criteria

Inclusion Criteria: Pregnant women infected with Sars-Cov-2. Delivery at Portuguese
maternities.

Exclusion Criteria: RT PCR SARS-CoV-2 negative.

-

Eligibility Gender
Female
Eligibility Age
Minimum: 16 Years ~ Maximum: 55 Years
Countries
Portugal
Locations

Nova Medical School - UNL
Lisbon, Portugal

Investigator: Nadia Charepe, MSc, MD
Contact: 00351213184000
nadia.charepe@chlc.min-saude.pt

Contacts

Nadia Charepe, MD,MSc
00351213184000
nadia.charepe@chlc.min-saude.pt

Alexandra Queirós, MD
00351213184000
alexandra.queiros@nms.unl.pt

Universidade Nova de Lisboa
NCT Number
MeSH Terms
Infections
Communicable Diseases
Coronavirus Infections
Pregnancy Complications